MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KNSA has $712,333K in assets. $176,950K in debts. $174,858K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
384.76%
Quick Ratio
351.26%
Cash Ratio
141.48%
Debt to Asset Ratio
24.84%
Assets Breakdown
    • Deferred tax assets
    • Short-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued collaboration expenses
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
174,858 192,037
Short-term investments
177,244 115,745
Accounts receivable, net
51,742 31,910
Inventory
41,396 48,181
Prepaid expenses and other current assets
30,290 32,438
Total current assets
475,530 420,311
Property and equipment, net
1,655 1,076
Operating lease right-of-use assets
10,073 10,304
Other long-term assets
8,288 8,195
Intangible asset, net
15,500 15,750
Deferred tax assets
201,287 205,514
Total assets
712,333 661,150
Accounts payable
6,150 8,956
Accrued collaboration expenses
63,282 52,389
Accrued expenses
30,941 35,959
Operating lease liabilities
2,696 2,522
Other current liabilities
20,523 18,001
Total current liabilities
123,592 117,827
Non-current deferred revenue
31,811 31,811
Non-current operating lease liabilities
7,022 7,243
Other long-term liabilities
14,525 9,262
Total liabilities
176,950 166,143
Ordinary shares value-Common Class A
12 12
Ordinary shares value-Common Class B
1 1
Ordinary shares value-Common Class A1
4 4
Ordinary shares value-Common Class B1
4 4
Additional paid-in capital
1,011,854 989,811
Accumulated other comprehensive loss
-155 -53
Accumulated deficit
-476,337 -494,772
Total shareholders' equity
535,383 495,007
Total liabilities and shareholders' equity
712,333 661,150
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$30,290K Inventory$41,396K Accounts receivable, net$51,742K Short-term investments$177,244K Cash and cashequivalents$174,858K Deferred tax assets$201,287K Intangible asset, net$15,500K Other long-termassets$8,288K Operating leaseright-of-use assets$10,073K Property and equipment,net$1,655K Total current assets$475,530K Total assets$712,333K Total liabilities andshareholders' equity$712,333K Total shareholders'equity$535,383K Total liabilities$176,950K Accumulated deficit-$476,337K Accumulated othercomprehensive loss-$155K Additional paid-in capital$1,011,854K Other long-termliabilities$14,525K Non-current operating leaseliabilities$7,022K Non-current deferredrevenue$31,811K Total currentliabilities$123,592K Ordinary sharesvalue-Common Class B1$4K Ordinary sharesvalue-Common Class A1$4K Ordinary sharesvalue-Common Class B$1K Ordinary sharesvalue-Common Class A$12K Other currentliabilities$20,523K Operating leaseliabilities$2,696K Accrued expenses$30,941K Accrued collaborationexpenses$63,282K Accounts payable$6,150K

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA)